Skip to main content
. 2015 Apr 9;26(2):90–99. doi: 10.3802/jgo.2015.26.2.90

Table 1. Clinicopathologic characteristics and surgical outcomes.

Characteristic CRH (n=40) NSRH (n=46) p-value
Age (yr) 49.5±9.1 46.7±9.4 NS*
BMI (kg/m2) 25.4±3.2 24.3± 2.2 NS*
FIGO stage NS
 IB1 31 (77.5) 34 (74.0)
 IB2 3 (7.5) 6 (13.0)
 IIA 6 (15.0) 6 (13.0)
Tumor size (cm) 2.5±1.1 2.1±1.3 NS*
Histologic type NS
 Squamous cell carcinoma 33 (82.5) 35 (76.0)
 Adenocarcinoma 6 (15.0) 11 (23.9)
 Adenosquamous carcinoma 1 (2.5) 0
Operation time (min) 278 (244-321) 297 (256-368) NS
Estimated blood loss (mL) 520.8±239.8 478.9±206.5 NS*
Radicality
 Paracervical length, right (cm) 4.7±1.4 4.2±0.9 NS*
 Paracervical width, right (cm) 3.6±0.8 3.7±1.0 NS*
 Paracervical length, left (cm) 4.8±1.4 4.2±1.0 NS*
 Paracervical width, left (cm) 3.3±0.8 3.6±0.9 NS*
 Vaginal length (cm) 3.0±0.8 3.0±0.6 NS*
 No. of harvested pelvic LN 25.8±7.8 26.9±8.1 NS*
 No. of harvested para-aortic LN 5.9±4.7 6.2±4.8 NS*
LN involvement 2 (5.0) 4 (8.7) NS
No. of dissected nerve fibers 30 (17-45) 12 (6-21) <0.001
Postoperative complication 3 (7.5) 2 (4.3) NS
 Incisional hernia 1 1
 Infected lymphocele 2 1
No. of cases of CIC 3 (7.5) 0 <0.001
Days for RU <50 mL 18 (10-85) 11 (7-26) <0.001
Postoperative radiotherapy 15 (37.5) 14 (31.1) NS
Follow-up duration (mo) 101 (13-137) 111 (13-139) NS*
Recurrence 2 (5.0) 3 (6.5) NS
10-Year DFS (%) 94.9 92.4 NS§

Values are presented as mean±SD, number (%), or median (range).

BMI, body mass index; CIC, clean intermittent catheterization; CRH, conventional radical hysterectomy; DFS, disease-free survival; FIGO, International Federation of Gynecology and Obstetrics; LN, lymph node; NS, not significant; NSRH, nerve-sparing radical hysterectomy; RU, residual urine.

*Student t-test. Fisher exact test. Mann-Whitney test. §Kaplan-Meier survival analysis.